The Application of Glycolipid-Type Microbial Biosurfactants as Active Pharmaceutical Ingredients for the Treatment and Prevention of Cancer
Pharmaceutical scientists have researched the potential of secondary metabolites biosynthesized by microorganisms as active pharmaceutical ingredients (APIs) for the treatment of cancer. Ideally, these APIs should possess anticancer bioactivity that specifically targets tumor cells while having litt...
Saved in:
| Main Authors: | Aileen M. B. McMahon, Matthew S. Twigg, Roger Marchant, Ibrahim M. Banat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/5/676 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bubbling insights: unveiling the true sophorolipid biosynthetic pathway by Starmerella bombicola
by: Sophie L. K. W. Roelants, et al.
Published: (2024-08-01) -
Applications of rhamnolipid biosurfactants in agriculture
by: Elise Pierre, et al.
Published: (2025-03-01) -
Cytotoxicity evaluation of microbial sophorolipids and glucolipids using normal human dermal fibroblasts (NHDF) in vitro
by: Sergio Oliveira Formoso, et al.
Published: (2025-06-01) -
Bioremediation of crude oil and heavy metal pollutants in marine environment by biosurfactant, rhamnolipid isolated from Stutzerimonas stutzeri − MW15
by: J.B. Sony, et al.
Published: (2025-09-01) -
Structure Elucidation and Characterization of Novel Glycolipid Biosurfactant Produced by <i>Rouxiella badensis</i> DSM 100043<sup>T</sup>
by: Andre Fahriz Perdana Harahap, et al.
Published: (2025-04-01)